Avicel, Mirocrystalline cellulose, packaged in bulk as PH101 NF, PH102 NF, PH200 NF, Manufactured...
FDA Drug Recall #D-0728-2021 — Class III — August 5, 2021
Recall Summary
| Recall Number | D-0728-2021 |
| Classification | Class III — Low risk |
| Date Initiated | August 5, 2021 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | DuPont Nutrition USA, Inc |
| Location | Newark, DE |
| Product Type | Drugs |
| Quantity | 2,384,720 kg |
Product Description
Avicel, Mirocrystalline cellulose, packaged in bulk as PH101 NF, PH102 NF, PH200 NF, Manufactured by: DuPont Nutrition USA, Inc., 1301 Ogletown Road, Newark, DE 19711
Reason for Recall
Out of specification results for conductivity.
Distribution Pattern
Product was distributed nationwide, including Puerto Rico and to foreign accounts abroad.
Lot / Code Information
Lot Numbers: P120834253, PN20834314, PN20834326, P220834329, P120834471, 2173728724, 2173731307, 2173739294, 2173742956, 2173743721, 2173747040 217374970, 2173749846, 2173751395, 2173751995, 2173753080, 2173749460, 2173755135, 2173755142, 2173758869, 22173758869 2173759101, 2173759087, 2173760958, 21737606959, 2173762248, 217376233, 2173763871 2173763872, 2173755139, 2173763875, 2173764734, 2173763870, 2173764735, 2173769670, 2173775381, 2173776518, 217377536, 2173779284, 2173800414, 2173801736, 2173801737, 2173802516, 2173805796, 2173805797, 2173806449, 2173806450, 2173809474, 2173809473 2173810873, 2173811314, 2173811315, 2173806441, 217381169, 2173811666 These excipients are noted not to have an expiration date.
Other Recalls from DuPont Nutrition USA, Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0546-2023 | Class III | Avicel PH-200 NF, Microcrystalline Cellulose NF... | Apr 13, 2023 |
| D-0547-2023 | Class III | Avicel DG, MCC/Dibasic Calcium Phosphate, Net C... | Apr 13, 2023 |
| D-0545-2023 | Class III | Avicel PH-102 NF, Microcrystalline Cellulose NF... | Apr 13, 2023 |
| D-0544-2023 | Class III | Avicel PH-101 NF, Microcrystalline Cellulose NF... | Apr 13, 2023 |
| D-0352-2023 | Class III | BD-102 NF, Microcrystalline Cellulose, NF, Ph. ... | Feb 1, 2023 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.